| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 73-77 |
| Número de páginas | 5 |
| Publicación | ChemMedChem |
| Volumen | 7 |
| N.º | 1 |
| DOI | |
| Estado | Published - ene 2 2012 |
Financiación
| Financiadores | Número del financiador |
|---|---|
| National Institute of Allergy and Infectious F32-AI286447 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI168214 Jason W. Rosch Diseases National Institute of Allergy and Infectious P30 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R00-AI166116 Christopher D. Radka Diseases National Institute of Allergy and Infectious T32-AI106700 Cydney N. Johnson Diseases National Institute of Allergy and Infectious R01AI192221 Jason W. Rosch Diseases National Inst... | R01AI090048 |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Pharmacology
- Drug Discovery
- General Pharmacology, Toxicology and Pharmaceutics
- Organic Chemistry
Huella
Profundice en los temas de investigación de 'Identification and characterization of inhibitors of the aminoglycoside resistance acetyltransferase Eis from Mycobacterium tuberculosis'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver